|
Myasthenia Gravis Research Highlights: AAN 2023
This 30-minute CME program highlights the latest clinical research about myasthenia gravis, a rare, autoimmune disease that targets the neuromuscular junction.
Treatment of myasthenia gravis is highly individualized and depends greatly on the myasthenia gravis subtype of each patient as well as each patient’s comorbidities. There are currently four drugs approved by the FDA, eculizumab, efgartigimod, ravulizumab, and rozanolixizumab. There are also treatments in development. Clinical tria... |
|
|
Myasthenia Gravis and the Complement System
This 45-minute CME-accredited program, hosted by James F Howard Jr, MD, Professor of Neurology, Medicine & Allied Health at The University of North Carolina at Chapel Hill, highlights the connection between the complement system and myasthenia gravis in regards to the pathophysiology and treatment of this rare disease.
After participating in the activity, learners should be better able to:
- Review the pathophysiology of MG.
- Describe the role of the complement system in MG.
- Descr... |
|
|
Duchenne Muscular Dystrophy: Recognizing Its Earliest Signs in Infancy and Care Transition into Adulthood
Target Audience
The intended audience for this activity are neurologists, neuromuscular specialists, pediatric neurologists, genetic counselors, and pediatricians.
Program Overview
Join a panel of expert clinicians to identify the subtle and very early signs of DMD that may be detected before functional symptoms are noticed and that can help earlier diagnoses and appropriate interventions. Panelists will review the importance of matching mutations to therapeutic decisions, discuss emergin... |
|
|
Cleveland Clinic 13th Annual Neurology Update
Cleveland Clinic’s 13th Annual Neurology Update features a faculty of more than a dozen thought leaders discussing the most current clinically focused information regarding diagnosis, medication and therapy for a wide variety of neurologic conditions. This comprehensive review will detail strategies, procedures and best practices throughout the specialty. Neurologists, general practitioners, nurses and physician assistants will all benefit from the latest information impacting the practice... |
|
|
Thymidine Kinase 2 Deficiency: From Diagnostic Odyssey to Timely Diagnosis and Treatment
Mary Kay Koenig, MD, a leader in the management of patients with mitochondrial diseases, delves into the complexities of managing patients with thymidine kinase 2 deficiency (TK2d). In this 1-hour activity, Dr. Koenig shares her insights in the clinical presentation of TK2d through real case studies and offers guidance on overcoming the ‘diagnostic odyssey’ experienced by many patients with mitochondrial disease. She also discusses the clinical criteria for referring patients to specialize... |
|
|
The IMPACT Initiative Learning Center: Shoulder and Arm
Target Audience
This activity is intended for neurologists, physiatrists, orthopedic surgeons, residents, fellows, nurse practitioners, physician assistants, physical therapists, and occupational therapists who manage patients with spasticity and movement disorders.
Program Overview
This activity reviews utilization of ultrasound guidance for optimizing botulinum neurotoxin (BoNT) injections in the shoulder girdle region including pattern recognition, scanning tips, and needle guidanc... |
|
|
The IMPACT Initiative Learning Center: Lower Limb/leg and Calf Region
Target Audience
This activity is intended for neurologists, physiatrists, orthopedic surgeons, residents, fellows, nurse practitioners, physician assistants, physical therapists, and occupational therapists who manage patients with spasticity and movement disorders.
Program Overview
This activity reviews use of ultrasound guidance for optimizing botulinum neurotoxin injections in the leg and calf region including pattern recognition, scanning tips, and needle guidance techniques
Le... |
|
|
The IMPACT Initiative Learning Center: Forearm and Hand
Target Audience
This activity is intended for neurologists, physiatrists, orthopedic surgeons, residents, fellows, nurse practitioners, physician assistants, physical therapists, and occupational therapists who manage patients with spasticity and movement disorders.
Program Overview
This activity reviews use of ultrasound guidance for optimizing botulinum neurotoxin injections in the forearm and hand including pattern recognition, scanning tips, and needle guidance techniques.
Lear... |
|
|
Physical Assessment - A Certificate Training Workshop for Pharmacy Practitioners
As pharmacists expand their scope of practice under
new legislation (SB493), physical assessment is a key
skill necessary for advanced practice. This 21 hour
course will prepare the pharmacist to obtain a
history and perform a basic physical examination
that will enable them to assess and monitor drug
therapy. The course will employ written materials,
videos, lectures, demonstrations and hands on
practice and feedback
Objectives for Pharmacists
At the conclusion of the course the p... |
|